Few & Far Between

Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for conversations on the cutting edge - from clinical research and policymakers to rare disease advocates and industry leaders.

Latest Episodes

44

October 23, 2024 00:44:29
Episode Cover

Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics

"We don't endeavor to make elite athletes better. We endeavor to make society healthier." - Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics Welcome...

Listen

43

September 12, 2024 00:39:18
Episode Cover

Episode 43: Isaac Stoner, Co-founder and CEO at Octagon Therapeutics

"I hope we're moving into the age of the generalist, where knowing how to learn and learning how to learn are more important than...

Listen

42

July 16, 2024 00:36:14
Episode Cover

Episode 42: Diana Azzam, PhD, Assistant Professor at Florida International University, Co-Founder at First Ascent Biomedical

“Our studies are open for those that have exhausted standard of care, and we're showing improved responses, and the data is promising. So, I...

Listen

38

May 23, 2024 00:35:24
Episode Cover

Episode 41: Craig Serra, Head of Clinical Research Scientific and Technical Engagement, Flatiron Health

"It's amazing how many companies there are and how many opportunities for a kind of a match between a human that needs some help...

Listen

40

April 25, 2024 00:33:23
Episode Cover

Episode 40: Professor Justin Stebbing, Editor-in-Chief, Oncogene journal

"I learned very early on that the stupidest cancer cell was cleverer than the cleverest oncologist." - Justin Stebbing, Editor-in-Chief of Oncogene, previously the...

Listen

39

March 26, 2024 00:45:10
Episode Cover

Episode 39: Dr. Keith Flaherty, Director of Clinical Research at Massachusetts General Hospital Cancer Center

"Technologies have changed enormously in terms of how we can basically procure, preserve, and then interrogate a tumor specimen...like effectively in real time, like...

Listen
Next